• 10.03.12

    Blackwell Burke P.A. Hosts Inaugural Meeting of Twin Cities E-Discovery Forum

    Blackwell Burke P.A. will host the inaugural meeting of the Twin Cities E-Discovery Forum.  The forum will be a quarterly gathering of local outside counsel, in-house counsel, public-sector attorneys, the judiciary, technologists, and IT professionals dedicated to sharing knowledge and experiences about e-discovery best practices to create a stronger Twin Cities e-discovery community. All are welcome to attend. The Forum’s first meeting will be from 7:30–9:00am on Tuesday, October 16, at 431 South 7th Street, Suite 2500, in Minneapolis. Blackwell Burke P.A. will host the meeting. Brendan M. Kenny is the founder of the Twin Cities E-Discovery Forum.  Mr. Kenny…
  • 09.19.12

    Blackwell Burke P.A. Partner Peter J. Goss Comments on Multi-District Litigation in Hip Implant Cases for Law 360

    Blackwell Burke P.A. partner Peter J. Goss was quoted recently in a Law360 article discussing the possible federal court consolidation of Biomet Inc.'s metal hip implant personal injury cases.  The device manufacturer will argue today that its cases are too varied to be consolidated into multi-district litigation.  The federal panel considering the consolidation, however, has already consolidated litigation for other similar cases involving metal implants.  In light of this precedent, Goss commented that the federal panel will likely follow suit in Biomet's case, unless Biomet shows that it is unlikely similar cases will be filed.  The article, "Past Metal-Hip Fights…
  • 09.07.12

    Law 360 and Drug and Device Law Blog Discuss Blackwell Burke P.A.’s Ninth Circuit Victory

    Law 360 and the Drug and Device Law Blog each recently explored Blackwell Burke P.A.’s  recent  victory in Egilman v. ConAgra Foods Inc., No. 10-35667.  In Egilman, the United States Court of Appeals for the Ninth Circuit dismissed the plaintiff’s expert’s independent appeal of a lower court decision that precluded the expert’s testimony and granted summary judgment to Blackwell Burke client ConAgra in one of the nation’s first consumer “popcorn lung” cases. The plaintiff’s expert argued on appeal that the district court judge’s 70-page Daubert opinion damaged his ability to make a livelihood.  Blackwell Burke attorneys argued that the plaintiff’s expert did not have…
  • 09.05.12

    Blackwell Burke P.A. Wins Ninth Circuit Appeal

    The Ninth Circuit has rejected a professional expert witness’s attempt to independently appeal the Daubert decision that excluded his testimony. In Egilman v. ConAgra Foods Inc., No. 10-35667, the appellate court found that the expert lacked independent standing to appeal the Daubert decision of the trial court in Newkirk v. ConAgra Foods Inc., 727 F. Supp. 2d 1006 (E.D. Wash. 2010), which the Ninth Circuit had already affirmed in a prior decision, 438 Fed. Appx. 607 (9th Cir. 2011).  Blackwell Burke successfully argued the original Daubert motion, the original appeal, and now the attempt by the excluded expert to independently appeal the exclusion of his testimony. Blackwell Burke…
  • 08.06.12

    Blackwell Burke P.A. Chairman Jerry W. Blackwell Featured in Star Tribune Viewpoint Article

    Star Tribune reporter Dave Phelps recently interviewed Blackwell Burke P.A. chairman and founding partner Jerry W. Blackwell. The Q-and-A style interview discussed Mr. Blackwell’s career as a trial lawyer, the firm, and how to explain complex cases to jurors. The full article is available on the Star Tribune website. Mr. Blackwell is an accomplished trial lawyer. He serves as national counsel and national trial counsel for major corporations, having represented them in federal and state courts in 47 states and internationally. Mr. Blackwell has received numerous honors, including: being a BTI Client Service All-Star; being named Minnesota Attorney of the Year;…
  • 07.26.12

    Blackwell Burke P.A. Partner Peter J. Goss Comments on Proposed Drug Legislation

    Blackwell Burke P.A. partner Peter J. Goss was quoted in a recent Law360 article discussing legislation introduced in Congress requiring manufacturers of opiate painkillers to make the drugs more difficult to convert into a form susceptible to abuse. Goss commented on the economic impact that this law could have on generic drug makers by requiring them to develop or license anti-abuse technology. The article is available here. Mr. Goss focuses his national practice on pharmaceutical and medical device product liability litigation and toxic torts. He has represented major pharmaceutical, medical technology, and chemical firms in hundreds of cases. Mr. Goss,…

Interested in learning more?

Email Disclaimer Close

Sending us an email will not make you a client of our firm. Until we have agreed to represent you, nothing you send us will be confidential or privileged.

If your email is related to representation, the best way for you to inquire about a possible representation is to call a Blackwell Burke P.A. attorney at one of the telephone numbers listed on our Attorney's page. An attorney will first take you through our conflict of interest procedure and see that you are put in touch with the lawyer best suited to handle your matter.

If you proceed with an email, you confirm that you have read and understand this notice. To proceed, click I Agree.